Tailoring Basal Bolus Therapy for T2D Patients

Introduction

In this lecture,Dr. Nasser Al Juhani will explain the importance of early and timely glycemic control for patients with T2D while highlighting on how biosimilars are developed and how they work for the patient characteristic that will benefit from adding rapid acting insulin to their regimen.

Objectives

• Understanding the importance of early and timely glycemic control for patients with diabetes.
• Understanding how biosimilars are developed and how they work.
• Identify patient characteristics most appropriate to add rapid acting insulin to their regimen.

This Course For :

Resident / Fellow ( Cardiology , Endocrinology & Metabolism , Family Medicine , Internal Medicine , Nephrology , General Practitioners )
Physician ( Cardiology , Endocrinology & Metabolism , Family Medicine , Internal Medicine , Nephrology , General Practitioners )

Sponsored by :

Price

Course Fee

FREE

FREE
VAT Included
See Registration Policies, Cancellations & Refunds

Contact Information

Organization : Virtual Medical Academy
Phone : 920008161
Email : [email protected]

  • 15 Sep 2021    To    23 Sep 2021
  • 08:30 PM  To  11:59 PM
  • Certificate Available
  • Online Recorded
  • 913
  Add to Calendar 09/15/2021 08:30 PM 09/23/2021 11:59 PM Asia/ Riyadh Tailoring Basal Bolus Therapy for T2D Patients Tailoring Basal Bolus Therapy for T2D Patients https://medicalacademy.org/portal/event/view/1554